查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737144

全球糖球市场规模（按产品、应用、地区、范围和预测）

Global Sugar Sphere Market Size By Product(Standard Spheres and Microspheres), By Application(Tablets and Capsules), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

糖球市场规模及预测

2024 年糖球市场规模价值 1.7028 亿美元，预计到 2032 年将达到 2.797 亿美元，2026 年至 2032 年的复合年增长率为 6.40%。

製药业和新兴国家日益增长的需求将显着推动市场成长。患者友善的剂量也刺激了全球糖球市场的需求。本报告对全球糖球市场进行了全面评估，并对关键细分市场、趋势、市场驱动因素、竞争格局以及影响市场的关键因素进行了全面分析。

定义全球糖球市场

糖球，又称中性小丸、中性芯、无糖种子、颗粒剂、糖珠或微球，是白色种子，通常由蔗糖（至少 62.5%）和淀粉製成，常采用分层糖衣结构。糖球首先用活性剂和缓释性赋形剂包衣。小丸是药物的起点，并与其他成分混合，例如活性药物成分 (API)。它们可以用作缓释性中的中性起始芯，填充到胶囊或压成锭剂。糖球特别适合用于组合药物，因为最常见于缓释片。

糖球主要用作胶囊和锭剂的惰性芯材。它们为药物提供包衣基质，药物通常会在其上包覆一层促进释放的聚合物。糖球的球形形状得益于其良好的流动性，尤其是在大量灌注时。此外，将糖球与原料药和其他辅料混合，然后压製成片。对于球形糖锭剂，这种方法更简单、更有效。糖球不仅用于口服製剂，也用于食品。

糖球主要分为两种：微球和标准球。微糖球的粒径为100-500微米，标准糖球的粒径为0.5-2毫米。为确保原料药的稳定分布，应谨慎控製糖球的粒径。国际筛组说明了美国材料与试验协会 (ASTM) 标准筛设定的粒径μm参数。糖球因其低易碎性而具有吸引力，这使得它们能够承受锭剂包装、处理和其他製造工艺的严格要求。

全球糖球市场概览

糖球通常是由蔗糖和淀粉製成的多孔小球。这些小球与其他锭剂成分混合，例如构成锭剂核心的活性药物成分 (API)。由于它们最常用于缓释片，因此混合物中还含有其他赋形剂。它们的球形使其具有理想的流动性，尤其是在大量倒出时。糖球易碎性低，这使得它们能够承受费力的锭剂包衣、给药和其他製造步骤。此外，将小球与活性药物成分 (API) 和其他赋形剂混合后压制新形成的锭剂，使用球形小球更简单、更有效。然而，使用糖球製备药物锭剂和胶囊需要各种技术，这会导致高昂的製造成本。预计较长的加工时间和高昂的製造成本将限制全球糖球市场的成长。

糖球主要用作锭剂的惰性核心，尤其是多颗粒缓释性。糖球为药物提供包衣基础，通常用释放调节聚合物包衣。此外，随着製药公司寻求提高临床疗效，多颗粒药物输送流程正在兴起。预计未来几年糖球仍将是固态药物产品中的重要辅料，并可成功用作新的开发方法。糖球被视为以小丸形式给药的各种药物产品的关键成分。在研究中，糖球已证明其与其他概念相比的价值。由于糖球具有许多优势，新的应用不断涌现，例如压缩包衣小丸以生产缓释片和多单元锭剂。糖球列入美国食品药物管理局(FDA) 的口服锭剂和锭剂惰性成分指南。它们也被列入英国和欧洲核准的肠外製剂中。

目录

第一章 引言

  • 市场定义
  • 市场区隔
  • 调查时间表
  • 先决条件
  • 限制

第二章调查方法

  • 资料探勘
  • 二次调查
  • 初步调查
  • 专家建议
  • 品质检查
  • 最终审核
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 资料来源

第三章执行摘要

  • 市场概览
  • 全球糖球市场按地区分析
  • 全球糖球市场，按应用
  • 全球糖球市场（按产品）
  • 未来市场机会
  • 全球市场区隔

第四章 市场展望

  • 全球糖球市场前景
  • 市场驱动因素
    • 全球吸毒现象呈上升趋势
    • 糖丸相对于其他辅料的优势
  • 市场限制
    • 製造成本高
    • 市场上的替代品供应情况
  • 市场机会
    • 加强医学创新
  • Covid19对全球糖球市场的影响
  • 波特五力分析

第五章 按产品分類的市场

  • 概述
  • 微米
  • 标准球

第六章 按应用分類的市场

  • 概述
  • 胶囊
  • 锭剂

第七章 区域市场

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 中东和非洲
    • 拉丁美洲

第八章 竞争态势

  • 概述
  • 竞争场景
  • 企业市场排名分析

第九章 公司简介

  • COLORCON
  • PHARM-A-SPHERES
  • MB SUGARS AND PHARMACEUTICALS LIMITED
  • PHARMATRANS SANAQ AG
  • EMILIO CASTELLI
  • NANJING JOYFULCHEM
  • MEENAXY PHARMA PVT. LTD.
简介目录
Product Code: 53101

Sugar Sphere Market Size And Forecast

Sugar Sphere Market size was valued at USD 170.28 Million in 2024 and is projected to reach USD 279.7 Million by 2032, growing at a CAGR of 6.40% from 2026 to 2032.

Increased demand from the pharmaceutical industry and from emerging countries will significantly drive the growth of the market. Patient-friendly dosages also raise the demand for the Global Sugar Sphere Market. The Global Sugar Sphere Market provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Sugar Sphere Market Definition

Sugar spheres are also known as neutral pellets, neutral cores, non-pareil seeds, micro granules, sugar beads, and microspheres, are white seeds, typically made up of sucrose (min. 62.5%) and starch, produced often by using a layered sugar-coating structure. Sugar spheres are first covered with the active agent and the sustained release of additives. Comprising the origin of the medication, the pellets are mixed with other ingredients of the medicine, such as active pharmaceutical ingredients (APIs). It can be used as a neutral starter core for slow-release formulations filled in capsules or compressed in tablets. The use of sugar spheres is highly appropriate especially for combination drugs as they are most commonly found in the sustained-release tablets, other excipients can also be used in the mixture.

The sugar spheres are mainly used as an inert core in capsules and tablet formulations. They form the base upon which a drug is coated, usually followed by a release-modifying polymer coating. Its spherical shape is perfect due to its flowability, especially when poured in bulk. Further, after mixing the pellet with APIs and other excipients, the compression of the freshly produced tablet occurs; this method is simpler and more effective with the spherical pellet. The sugar spheres are not only used in oral pharmaceutical formulation but it also used in edible food products.

Sugar spheres are mainly classified into two types i.e. Microspheres and Standard Spheres. The micro sugar spheres are available in the full range from 100 to 500 micrometers and the standard sugar spheres range from 0.5 to 2 millimeters. In order to assure the consistent distribution of APIs, the particle size of sugar spheres should be carefully handled. The international set of sieves describes μm parameters for particle size set by the American Society for Testing and Materials (ASTM) standardized sieves. Sugar spheres are attractive due to their low friability, which helps them to survive rigorous tablet packaging, handling, and other manufacturing processes.

Global Sugar Sphere Market Overview

Sugar spheres are usually porous pellets consisting of sucrose and starch. The pellets are mixed with other tablet ingredients comprising the core of a tablet, such as active pharmaceutical ingredients (APIs). Since they are most commonly contained in the sustained-release tablets, the mixture can also contain other excipients. Its sphere-shaped is ideal owing to its flowability, mostly when poured in bulk. The low friability of sugar spheres allows them to withstand the laborious tablet coating, control, and other production processes. In addition to this, compression of the newly-formed tablet comes after mixing the pellet with active pharmaceutical ingredients (APIs) and other excipients, this process is simpler and more effective with a spherical pellet. However, the preparation of pharmaceutical tablets and capsules using sugar spheres involves various technologies with high production costs. The long processing time and high production cost are expected to restrict the growth of the global sugar spheres market.

Sugar Spheres are primarily utilized as inert cores in tablets and capsules formulations, especially multiparticulate sustained-release formulations. They create the base upon that a pharmaceutical drug is coated, generally followed by release modifying polymer coating. In addition to this, multiparticulate drug delivery process is increasing as pharma companies seek to enhance clinical effectiveness. . Sugar spheres are expected to be a crucial excipient for solid medications in the coming years too with the probability of being utilized successfully as a method for new developments. Sugar spheres are considered as key ingredients in various medications administered in the pellet form. In research studies, sugar spheres have proven their worth compared to their alternative concepts. Due to the numerous benefits of sugar spheres, new applications are continuing to emerge, including compressing coated pellets to manufacture sustained-release tablets or multiple unit tablets. Sugar spheres are included in the Food and Drug Administration (FDA) Inactive Ingredients Guide for oral tablets and tablets. They are also included in non-parenteral drugs approved in the UK and Europe.

Global Sugar Sphere Market: Segmentation Analysis

The Global Sugar Sphere Market is segmented on the basis of Product, Application, and Geography.

Sugar Sphere Market By Product

  • Micrometers
  • Standard Spheres

On the basis of Product, the Global Sugar Spheres Market has been segmented into Standard Spheres and Microspheres. Standard Spheres accounted for the largest market share in 2019. The increasing application of standard sugar spheres for sustained-release pellet formulations is a key growth driver for the standard sphere's market.

Sugar Sphere Market By Application

  • Capsules
  • Tablet

Based on Application, the market is bifurcated into Tablets and Capsules. Tablets accounted for the largest market share in 2019. It is of great advantage to laboratories needing a number of sizes for different tablets. Sugar spheres are beneficial due to their low friability. It enables them to withstand the rigorous tablet coating, handling, and other manufacturing processes. The demand for pharmaceutical tablets is booming, with no sign of slowing up in the near future. Moreover, a rise in the prevalence of infectious & non-infectious disease and advancement in the healthcare sector are the factors that are expected to boost the adoption of sugar spheres in tablet development.

Sugar Sphere Market By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

On the basis of regional analysis, the Global Sugar Spheres Market is classified into North America, Europe, Asia Pacific, and Rest of the World (RoW). An increasing demand for pharmaceutical excipients, from pharmaceutical and biopharmaceutical industries in the United States, is the primary factor which is expected to propel the growth of the sugar sphere market in the North America region. In 2016, North America was the largest supplier of sugar sphere. Sugar spheres are the excipient for sustained-release pellet formulations used in oral dosage forms. Oral dosage form is the largest category of pharmaceutical dosage formulations. Thus, oral pharmaceuticals tend to require more excipients. The growing requirement of sugar sphere excipients (for fillers, binders, coatings, flavoring agents, capsules, and disintegrates from the pharmaceutical industries) in the United States is expected to foster the growth of the sugar sphere market.

Key Players

The major players in the market are Colorcon, Pharm-a-spheres, Pharmatrans Sanaq Ag, M. B. Sugars & Pharmaceuticals Limited, Emilio Castelli, Nanjing Joyfulchem, and Meenaxy Pharma Private Limited.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP DOWN APPROACH
  • 2.1 RESEARCH FLOW
  • 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 GLOBAL SUGAR SPHERES MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.3 GLOBAL SUGAR SPHERES MARKET, BY APPLICATION (USD MILLION)
  • 3.4 GLOBAL SUGAR SPHERES MARKET, BY PRODUCT (USD MILLION)
  • 3.5 FUTURE MARKET OPPORTUNITIES
  • 3.6 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL SUGAR SPHERES MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 GROWING USE OF MEDICATIONS ACROSS THE GLOBE
    • 4.2.2 ADVANTAGES OF SUGAR SPHERES OVER OTHER EXCIPIENTS
  • 4.3 MARKET RESTRAINTS
    • 4.3.1 HIGH PRODUCTION COST
    • 4.3.2 AVAILABILITY OF ALTERNATIVE SUBSTITUTES IN THE MARKET
  • 4.4 MARKET OPPORTUNITIES
    • 4.4.1 INCREASING INNOVATION IN THE MEDICATION SECTOR
  • 4.5 IMPACT OF COVID19 ON THE GLOBAL SUGAR SPHERES MARKET
  • 4.6 PORTER'S FIVE FORCES ANALYSIS

5 MARKET, BY Product

  • 5.1 OVERVIEW
  • 5.2 Micrometers
  • 5.3 Standard Spheres

6 MARKET, BY Application

  • 6.1 OVERVIEW
  • 6.2 Capsules
  • 6.3 Tablet

7 MARKET, BY GEOGRAPHY

  • 7.1 OVERVIEW
  • 7.2 NORTH AMERICA
    • 7.2.1 U.S.
    • 7.2.2 CANADA
    • 7.2.3 MEXICO
  • 7.3 EUROPE
    • 7.3.1 GERMANY
    • 7.3.2 U.K.
    • 7.3.3 FRANCE
    • 7.3.4 REST OF EUROPE
  • 7.4 ASIA PACIFIC
    • 7.4.1 CHINA
    • 7.4.2 JAPAN
    • 7.4.3 INDIA
    • 7.4.4 REST OF APAC
  • 7.5 ROW
    • 7.5.1 MIDDLE EAST AND AFRICA
    • 7.5.2 LATIN AMERICA

8 COMPETITIVE LANDSCAPE

  • 8.1 OVERVIEW
  • 8.2 COMPETITIVE SCENARIO
  • 8.3 COMPANY MARKET RANKING ANALYSIS

9 COMPANY PROFILES

  • 9.1 COLORCON
    • 9.1.1 COMPANY INSIGHTS
    • 9.1.2 PRODUCT BENCHMARKING
    • 9.1.3 KEY DEVELOPMENTS
    • 9.1.4 SWOT ANALYSIS
  • 9.2 PHARM-A-SPHERES
    • 9.2.1 COMPANY OVERVIEW
    • 9.2.2 COMPANY INSIGHTS
    • 9.2.3 PRODUCT BENCHMARKING
    • 9.2.4 SWOT ANALYSIS
  • 9.3 M B SUGARS AND PHARMACEUTICALS LIMITED
    • 9.3.1 COMPANY OVERVIEW
    • 9.3.2 COMPANY INSIGHTS
    • 9.3.3 PRODUCT BENCHMARKING
    • 9.3.4 SWOT ANALYSIS
  • 9.4 PHARMATRANS SANAQ AG
    • 9.4.1 COMPANY OVERVIEW
    • 9.4.2 COMPANY INSIGHTS
    • 9.4.3 PRODUCT BENCHMARKING
    • 9.4.4 SWOT ANALYSIS
  • 9.5 EMILIO CASTELLI
    • 9.5.1 COMPANY OVERVIEW
    • 9.5.2 COMPANY INSIGHTS
    • 9.5.3 PRODUCT BENCHMARKING
  • 9.6 NANJING JOYFULCHEM
    • 9.6.1 COMPANY OVERVIEW
    • 9.6.2 COMPANY INSIGHTS
    • 9.6.3 PRODUCT BENCHMARKING
  • 9.7 MEENAXY PHARMA PVT. LTD.
    • 9.7.1 COMPANY OVERVIEW
    • 9.7.2 COMPANY INSIGHTS
    • 9.7.3 PRODUCT BENCHMARKING